Transfasten Lsf
Payments companies reported to CMS as associated with Transfasten Lsf. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Transfasten Lsf, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Transfasten Lsf
These are the largest totals companies reported as associated with Transfasten Lsf. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mark Coleman | Pikesville, MD | Interventional Pain Medicine | $8,585.18 |
| Christian Klare | Nashua, NH | Orthopaedic Surgery | $1,100.00 |
| Charles Park | Baltimore, MD | Neurological Surgery | $151.56 |
| Amir Qureshi | Little Rock, AR | Interventional Pain Medicine | $65.73 |
| Chester Donnally | Addison, TX | Orthopaedic Surgery of The Spine | $49.30 |
| Ferras Albitar | East Providence, RI | Orthopaedic Surgery | $38.70 |
Prescribed Transfasten Lsf?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.